US 2002/0165277 A1 · Virucidal compositions

Abstract

A method of inactivating enveloped virus comprises contacting said virus with a virucidally effective amount of a composition comprising a C1 to C3 monohydroxy alcohol or a C3 to C4 diol and a sufficient amount of an acid to adjust the pH of the composition to below 4.6. Topical administration of the composition is preferred and is effective in treating lesions associated with herpes infections. Pharmaceutical compositions for use in the present method are provided.

Claims40

Dependent claims

A composition for inactivating an enveloped virus, consisting essentially of a C1-C3 alcohol or a C2-C4 diol and a sufficient amount of an acid to adjust the pH of the composition to 4.6 or less.

Dependencies are inferred from the claim text.

Facts

Application

09/795,279Filed 28 Feb 2001

Published

7 Nov 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/19
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids: carboxylic acids, e.g. valproic acid
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 31/045
Medicinal preparations containing organic active ingredients: hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
A61K 31/194
Carboxylic acids, e.g. valproic acid: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid

Abstract

Claims40

Dependent claims

A composition for inactivating an enveloped virus, consisting essentially of a C1-C3 alcohol or a C2-C4 diol and a sufficient amount of an acid to adjust the pH of the composition to 4.6 or less.

Dependencies are inferred from the claim text.

Virucidal compositions

Life of this patent

Abstract

Claims40

Virucidal compositions

Life of this patent

Abstract

Claims40